Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00874107 · COMPLETED
Trial details
- NCT number
- NCT00874107
- Sponsor
- HiberCell, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2016-04-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.